# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Piper Sandler analyst Jason Bednar maintains KORU Medical Systems (NASDAQ:KRMD) with a Overweight and raises the price targe...
Raising full year 2024 revenue guidance to $32.0-$32.5 million, representing year-over-year growth of 12-14%; raising full ye...
KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of ...
KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology compan...
The companies, KORU Medical, manufacturer of the proprietary, large-volume, Freedom Infusion System (the "Freedom System...
KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology compan...